FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sam Sanderson

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Living Beings

Mouse

Anatomy

Phenomena

Protein Binding

Physiology

Leukocyte Chemotaxis

Co-author Network

Publications

TOP 3
Mark L Hanke; Cortney E Heim; Amanda Angle; Sam D Sanderson; Tammy Kielian
Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections.
Sam D Sanderson; Homero Sepulveda; Marilyn L Thoman; Elizabeth L Virts; Stephanie Widmann; Edgar B Herrera; Kornelia Kis; Joy A Phillips
Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a.
Tamsin R Sheen; Marilyn L Thoman; Courtney K Cavaco; Celia M Ebrahimi; Edward L Morgan; Sam D Sanderson; Kelly S Doran
Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sam Sanderson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mark L Hanke; Cortney E Heim; Amanda Angle; Sam D Sanderson; Tammy Kielian
Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(5):2159-68.
2012: Sam D Sanderson; Homero Sepulveda; Marilyn L Thoman; Elizabeth L Virts; Stephanie Widmann; Edgar B Herrera; Kornelia Kis; Joy A Phillips
Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a.
PloS one 2012;7(7):e40303.
2011: Tamsin R Sheen; Marilyn L Thoman; Courtney K Cavaco; Celia M Ebrahimi; Edward L Morgan; Sam D Sanderson; Kelly S Doran
Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.
Vaccine 2011;30(1):9-13.
2009: Lavinia M Proctor; Tyson A Moore; Peter N Monk; Sam D Sanderson; Stephen M Taylor; Trent Woodruff
Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
International immunopharmacology 2009;9(6):800-6.
2008: Ganapati V Hegde; Erin Meyers-Clark; Shantaram S Joshi; Sam D Sanderson
A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells.
International immunopharmacology 2008;8(6):819-27.
2005: Diane S Allen-Gipson; Anthony A Floreani; Arthur J Heires; Sam D Sanderson; Richard G MacDonald; Todd A Wyatt
Cigarette smoke extract increases C5a receptor expression in human bronchial epithelial cells.
The Journal of pharmacology and experimental therapeutics 2005;314(1):476-82.
2004: Takashi Kurizaki; Michio Abe; Sam D Sanderson; Charles A Enke; Janina Baranowska-Kortylewicz
Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptides.
Molecular cancer therapeutics 2004;3(1):85-91.
2003: Anthony A Floreani; Todd A Wyatt; Julie A Stoner; Sam D Sanderson; Ethan G Thompson; Diane S Allen-Gipson; Arthur J Heires
Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion.
American journal of respiratory cell and molecular biology 2003;29(4):472-82.
2003: Chantey R Morris; Jason L Petersen; Shanna E Vargas; Heth R Turnquist; Mary M McIlhaney; Sam D Sanderson; Joseph T Bruder; Yik Y L Yu; Hans-Gerhard Burgert; Joyce C Solheim
The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expression.
The Journal of biological chemistry 2003;278(15):12618-23.
2003: Sam D Sanderson; Srinivasa R Cheruku; Maniyan Padmanilayam; Jonathan L Vennerstrom; Geoffrey M Thiele; Matthew Palmatier; Rick A Bevins
Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant.
International immunopharmacology 2003;3(1):137-46.
2002: Takashi Kurizaki; Shinji Okazaki; Sam D Sanderson; David Colcher; Charles A Enke; Margaret A Tempero; Janina Baranowska-Kortylewicz
Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(7):957-67.
2002: Ravindra Kashyap; Anthony A Floreani; Arthur J Heires; Sam D Sanderson; Todd A Wyatt
Protein kinase C-alpha mediates cigarette smoke extract- and complement factor 5a-stimulated interleukin-8 release in human bronchial epithelial cells.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2002;50(1):46-53.
2001: Shawn M Vogen; Natalii Paczkowski; L Kirnarsky; AJ Short; J B Whitmore; SA Sherman; Stephen M Taylor; Sam D Sanderson
Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation.
International immunopharmacology 2001;1(12):2151-62.
2001: Heth R Turnquist; Shanna E Vargas; Adrian Reber; Mary M McIlhaney; S Li; P Wang; Sam D Sanderson; B Gubler; Peter van Endert; Joyce C Solheim
A region of tapasin that affects L(d) binding and assembly.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(8):4443-9.
2001: Stuart A Cain; Trent Woodruff; Stephen M Taylor; David P Fairlie; Sam D Sanderson; Peter N Monk
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Biochemical pharmacology 2001;61(12):1571-9.
2001: Trent Woodruff; Anna J Strachan; Sam D Sanderson; Peter N Monk; AK Wong; David P Fairlie; Stephen M Taylor
Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.
Inflammation 2001;25(3):171-7.
2001: Stephen M Taylor; SA Sherman; L Kirnarsky; Sam D Sanderson
Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations.
Current medicinal chemistry 2001;8(6):675-84.
2000: J T Ulrich; W Cieplak; Natalii Paczkowski; Stephen M Taylor; Sam D Sanderson
Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(10):5492-8.
1999: AJ Short; Natalii Paczkowski; Shawn M Vogen; Sam D Sanderson; Stephen M Taylor
Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.
British journal of pharmacology 1999;128(3):511-4.
1999: Todd A Wyatt; Arthur J Heires; Sam D Sanderson; Anthony A Floreani
Protein kinase C activation is required for cigarette smoke-enhanced C5a-mediated release of interleukin-8 in human bronchial epithelial cells.
American journal of respiratory cell and molecular biology 1999;21(2):283-8.
1999: Shawn M Vogen; Om Prakash; L Kirnarsky; Sam D Sanderson; SA Sherman
Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin.
The journal of peptide research : official journal of the American Peptide Society 1999;54(1):74-84.
1999: Ian A Shiels; Sam D Sanderson; Stephen M Taylor
Arterially perfused eye model of uveitis.
Australian veterinary journal 1999;77(2):100-4.
1999: Shawn M Vogen; AM Finch; S K Wadi; J Thatcher; Peter N Monk; Stephen M Taylor; Sam D Sanderson
The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity.
The journal of peptide research : official journal of the American Peptide Society 1999;53(1):8-17.
1998: Anthony A Floreani; Arthur J Heires; Lisbeth Welniak; Amanda K Miller-Lindholm; L Clark-Pierce; Stephen I Rennard; EL Morgan; Sam D Sanderson
Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(10):5073-81.
1998: Shawn M Vogen; Om Prakash; L Kirnarsky; Sam D Sanderson; SA Sherman
NMR analysis of a potent decapeptide agonist of human C5a anaphylatoxin.
The journal of peptide research : official journal of the American Peptide Society 1998;51(3):226-34.
1997: AM Finch; Shawn M Vogen; SA Sherman; L Kirnarsky; Stephen M Taylor; Sam D Sanderson
Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
Journal of medicinal chemistry 1997;40(6):877-84.
1997: R R Buchner; Shawn M Vogen; W Fischer; ML Thoman; Sam D Sanderson; EL Morgan
Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptor.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(4):1670-80.
1997: Richard M Tempero; Michael A Hollingsworth; Michael D Burdick; AM Finch; Stephen M Taylor; Shawn M Vogen; EL Morgan; Sam D Sanderson
Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1377-82.
1996: R Kawatsu; Sam D Sanderson; I Blanco; N Kendall; AM Finch; Stephen M Taylor; David Colcher
Conformationally biased analogs of human C5a mediate changes in vascular permeability.
The Journal of pharmacology and experimental therapeutics 1996;278(1):432-40.
1995: AM Finch; A E Heron; S L Tolhurst; T H Florin; Sam D Sanderson; Stephen M Taylor
The effect of C5a and U46619 on the isolated, perfused human placental lobule: development of a method for the online estimation of tissue fluid accumulation.
Journal of pharmacological and toxicological methods 1995;34(3):133-41.
1995: Sam D Sanderson; F Perini
The synthesis and compositional analysis of phosphopeptides.
Molecular biotechnology 1995;4(2):139-49.
1995: Sam D Sanderson; L Kirnarsky; SA Sherman; Shawn M Vogen; Om Prakash; JA Ember; AM Finch; Stephen M Taylor
Decapeptide agonists of human C5a: the relationship between conformation and neutrophil response.
Journal of medicinal chemistry 1995;38(18):3669-75.
1995: SD Briggs; S S Bryant; Richard Jove; Sam D Sanderson; Thomas E Smithgall
The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.
The Journal of biological chemistry 1995;270(24):14718-24.
1994: Dana J Orten; J M Strawhecker; Sam D Sanderson; D Huang; Michael B Prystowsky; Steven H Hinrichs
Differential effects of monoclonal antibodies on activating transcription factor-1 and cAMP response element binding protein interactions with DNA.
The Journal of biological chemistry 1994;269(51):32254-63.
1994: Robert Lewis; Deanna J Volle; Sam D Sanderson
Phorbol ester stimulates phosphorylation on serine 1327 of the human insulin receptor.
The Journal of biological chemistry 1994;269(42):26259-66.
1994: Sam D Sanderson; L Kirnarsky; SA Sherman; JA Ember; AM Finch; Stephen M Taylor
Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activities.
Journal of medicinal chemistry 1994;37(19):3171-80.
1994: Isao Nishimori; F Perini; K P Mountjoy; Sam D Sanderson; N Johnson; R L Cerny; M L Gross; J D Fontenot; Michael A Hollingsworth
N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
Cancer research 1994;54(14):3738-44.
1994: Isao Nishimori; N R Johnson; Sam D Sanderson; F Perini; K Mountjoy; R L Cerny; M L Gross; Michael A Hollingsworth
Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat.
The Journal of biological chemistry 1994;269(23):16123-30.
1994: JA Ember; Sam D Sanderson; TE Hugli; E L Morgan
Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin.
The American journal of pathology 1994;144(2):393-403.
1993: E L Morgan; JA Ember; Sam D Sanderson; Wolfgang Scholz; R Buchner; Richard D Ye; TE Hugli
Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(1):377-88.
1992: E L Morgan; Sam D Sanderson; Wolfgang Scholz; D J Noonan; WO Weigle; TE Hugli
Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(12):3937-42.
1992: JA Ember; Sam D Sanderson; Stephen M Taylor; M Kawahara; TE Hugli
Biologic activity of synthetic analogues of C5a anaphylatoxin.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(10):3165-73.